15Nov 2022
Twelve years of assessing the quality of preimplantation genetic testing for monogenic disorders

Twelve years of assessing the quality of preimplantation genetic testing for monogenic disorders

Genomics Quality Assessment (GenQA) has provided external quality assessments (EQAs) for preimplantation genetic testing (PGT) for 12 years for eight monogenic diseases to identify sub‐optimal PGT strategies, testing and reporting of results which can be shared with the genomics community to aid optimised standards of PGT services for couples. The most common testing methodology was STR linkage analysis (59%). However, adoption of SNP‐based platforms was observed, and a move from blastomere to trophectoderm testing. There was variation in testing strategies, assigning marker informativity and understanding test limitations, some clinically unsafe. Critical errors were reported for genotyping and interpretation. EQA provides an overview of the standard of PGT‐M clinical testing and identifies areas of improvement for accurate detection of high-risk embryos.

  • #gynaecology - ivf

Like

Save

Share